Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD to launch new adverse event reporting service
Vets should continue reporting to manufacturers before the service launches.
The new service goes live on 20 May 2026.

The Veterinary Medicines Directorate (VMD) is to launch its new service for reporting adverse events associated with animal medicines.

A new digital service will go live on 20 May 2026, replacing the previous reporting tool, which is currently suspended.

The tool will enable veterinary professionals, Suitably Qualified Persons (SQPs) and animal owners to report adverse events directly to the VMD. This could include unexpected or harmful reactions in animals, or cases where the medicine does not work as expected.

It now provides users with additional guidance for creating a high-quality report. It is hoped that this will give the VMD more details from the outset.

The service will also be integrated with existing pharmacovigilance processes, which the VMD says will contribute to more efficient and comprehensive safety oversight.

It will initially be released as a beta version, through which users can provide feedback. This feedback will inform future system improvements.

Before the new portal is launched, veterinary professionals can continue reporting adverse events to the manufacturer of the medication. This company will then have a legal responsibility to share this report with the VMD within 30 days.

This will remain an option once the adverse event reporting portal has been launched.

To report adverse events relating to human medicine or medicine not approved for use in animals, users should email adverse.events@vmd.gov.uk to request a form.

Adverse event reporting is considered important to the VMD, helping the department work with medicine manufacturers to identify and respond to potential safety concerns. The VMD says that every report it receives improves its understanding of how medicines are performing in practice.

Image © Shutterstock.com/wavebreakmedia

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.